BG Medicine, Inc.
BGMD
$0.00
$0.000.00%
Weiss Ratings | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 229.72 | |||
Price History | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -- | |||
30-Day Total Return | -- | |||
60-Day Total Return | -- | |||
90-Day Total Return | -- | |||
Year to Date Total Return | -- | |||
1-Year Total Return | -99.00% | |||
2-Year Total Return | -- | |||
3-Year Total Return | -100.00% | |||
5-Year Total Return | -99.99% | |||
52-Week High % Change | -100.00% | |||
52-Week Low % Change | 0.00% | |||
Price | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.02 | |||
52-Week Low Price | $0.00 | |||
52-Week Low Price (Date) | Nov 22, 2023 | |||
52-Week High Price (Date) | Jun 06, 2023 | |||
Valuation | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 11.00 | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | 0.00 | |||
Earnings Per Share (TTM) | -0.74 | |||
Earnings Per Share Growth | -25.84% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 0.00 | |||
Price/Book (Q) | 0.00 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $0.00 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 11.26M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 781 890 1199 | |||
Address | 303 Wyman Street Waltham, MA 02451 | |||
Website | www.bg-medicine.com | |||
Country | United States | |||
Year Founded | 2000 | |||
Profitability | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -291.82% | |||
Profit Margin | -338.56% | |||
Management Effectiveness | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -77.59% | |||
Return on Equity | -- | |||
Income Statement | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.57M | |||
Total Revenue (TTM) | 1.57M | |||
Revenue Per Share | $0.14 | |||
Gross Profit (TTM) | 1.06M | |||
EBITDA (TTM) | -4.48M | |||
EBIT (TTM) | -4.57M | |||
Net Income (TTM) | -5.30M | |||
Net Income Avl. to Common (TTM) | -5.30M | |||
Total Revenue Growth (Q YOY) | -47.65% | |||
Earnings Growth (Q YOY) | 31.67% | |||
EPS Diluted (TTM) | -0.74 | |||
EPS Diluted Growth (Q YOY) | 44.81% | |||
Balance Sheet | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.53M | |||
Cash Per Share (Q) | $0.14 | |||
Total Current Assets (Q) | 1.95M | |||
Total Preferred Equity (Q) | 2.59 | |||
Total Equity (Q) | 618.00K | |||
Current Ratio (Q) | 1.653 | |||
Book Value Per Share (Q) | -$0.17 | |||
Total Assets (Q) | 2.13M | |||
Total Current Liabilities (Q) | 1.18M | |||
Total Debt (Q) | 0.00 | |||
Total Liabilities (Q) | 1.52M | |||
Total Common Equity (Q) | -1.98M | |||
Cash Flow | BGMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 13.00K | |||
Cash from Financing (TTM) | 1.06M | |||
Net Change in Cash (TTM) | -2.60M | |||
Levered Free Cash Flow (TTM) | -2.58M | |||
Cash from Operations (TTM) | -3.67M | |||